Andrew Pierce

Andrew Pierce

Company: Crescendo Biologics

Job title: VP Translational Biology

Seminars:

Live Q&A – Ask our Speakers Your Burning Questions 3:50 pm

Read more

day: Day One

CB307 Tri-Partite Humabody® Enhances T-Cells Through PSMA-Dependent CD137 (4-1BB) Agonism 3:00 pm

• CB307 monovalently binds PSMA, CD137 and HSA, to promote tumourspecific T-cell enhancement • Humabodies have superior tissue penetration relative to standard monoclonal antibodies • A CB307 mouse surrogate promotes tumour infiltration of CD8+ T-cells in PBMC engrafted mouse modelsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.